Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin receptor antagonists as therapeutic agents for insomnia
Ana Clementina Equihua-Benítez, Alberto K. De la Herrán-Arita, René Drucker-Colı́n
Frontiers in Pharmacology (2013) Vol. 4
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Murphy, Margaret Moline, David Mayleben, et al.
Journal of Clinical Sleep Medicine (2017) Vol. 13, Iss. 11, pp. 1289-1299
Open Access | Times Cited: 298
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
Mikko Kärppä, Jane Yardley, Kate Pinner, et al.
SLEEP (2020) Vol. 43, Iss. 9
Open Access | Times Cited: 127
The hypocretin (orexin) system: from a neural circuitry perspective
Shi‐Bin Li, Luı́s de Lecea
Neuropharmacology (2020) Vol. 167, pp. 107993-107993
Closed Access | Times Cited: 111
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial
Jane Yardley, Mikko Kärppä, Yuichi Inoue, et al.
Sleep Medicine (2021) Vol. 80, pp. 333-342
Open Access | Times Cited: 59
Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment
Laura Palagini, Pierre A. Geoffroy, Matteo Balestrieri, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Closed Access | Times Cited: 25
Sleep in vertebrate and invertebrate animals, and insights into the function and evolution of sleep
Shinichi Miyazaki, Chih-Yao Liu, Yu Hayashi
Neuroscience Research (2017) Vol. 118, pp. 3-12
Open Access | Times Cited: 82
Sleep Disruption at Home As an Independent Risk Factor for Postoperative Delirium
Oliver Todd, Lisa Gelrich, Alasdair M. J. MacLullich, et al.
Journal of the American Geriatrics Society (2017) Vol. 65, Iss. 5, pp. 949-957
Closed Access | Times Cited: 74
Early-life origin of adult insomnia: does prenatal–early-life stress play a role?
Laura Palagini, Christopher L. Drake, Philip Gehrman, et al.
Sleep Medicine (2015) Vol. 16, Iss. 4, pp. 446-456
Open Access | Times Cited: 66
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation
Carsten T. Beuckmann, Takashi Ueno, Makoto Nakagawa, et al.
SLEEP (2019) Vol. 42, Iss. 6
Open Access | Times Cited: 38
Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis
Hyun-jin Na, Nakyung Jeon, Christine E. Staatz, et al.
SLEEP (2023) Vol. 47, Iss. 2
Closed Access | Times Cited: 12
Japanese sake yeast supplementation improves the quality of sleep: a double‐blind randomised controlled clinical trial
Noriyuki Monoi, Ayumi Matsuno, Yuki Nagamori, et al.
Journal of Sleep Research (2015) Vol. 25, Iss. 1, pp. 116-123
Open Access | Times Cited: 39
Publication analysis on insomnia: how much has been done in the past two decades?
Yan Ma, Ming Dong, Carol Mita, et al.
Sleep Medicine (2015) Vol. 16, Iss. 7, pp. 820-826
Closed Access | Times Cited: 36
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation
Kevin G. Burfeind, Vijayshree Yadav, Daniel L. Marks
Current Neurology and Neuroscience Reports (2016) Vol. 16, Iss. 11
Open Access | Times Cited: 35
Orexin 2 receptor (OX2R) protein distribution measured by autoradiography using radiolabeled OX2R-selective antagonist EMPA in rodent brain and peripheral tissues
Kayo Mitsukawa, Haruhide Kimura
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Hippocampal orexin receptors: Localization and function
Mahmoud Elahdadi Salmani, Masoumeh Sarfi, Iran Goudarzi
Vitamins and hormones (2022), pp. 393-421
Closed Access | Times Cited: 17
2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults – Brazilian Sleep Association
Luciano F. Drager, Márcia Assis, Andrea Bacelar, et al.
Sleep Science (2023) Vol. 16, Iss. S 02, pp. 507-549
Open Access | Times Cited: 9
A Comprehensive Review of Lemborexant to Treat Insomnia.
Mitchell C. Fuller, Samuel F. Carlson, Chris M. Grant, et al.
PubMed (2024) Vol. 54, Iss. 1, pp. 43-64
Closed Access | Times Cited: 3
Headache, drugs and sleep
Alexander Nesbitt, Guy Leschziner, Richard Peatfield
Cephalalgia (2014) Vol. 34, Iss. 10, pp. 756-766
Closed Access | Times Cited: 34
Therapeutic implications of the choroid plexus–cerebrospinal fluid interface in neuropsychiatric disorders
Delphine Demeestere, Claude Libert, Roosmarijn E. Vandenbroucke
Brain Behavior and Immunity (2015) Vol. 50, pp. 1-13
Closed Access | Times Cited: 33
Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers
Yuhei Nishimura, Shiko Okabe, Shota Sasagawa, et al.
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 29
Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial
Yoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 4, pp. 581-592
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top